Our Team

Clinical Trial Consultants and Scientific Experts in PRO Methods and Measurements

The scientists of PRO Consulting have more than 255 collective years experience capturing and reporting patient reported outcomes (PRO) data to support drug and medical device development programs worldwide. Our experience includes consulting on more than 270 U.S. and international clinical trials, including participation in Scientific Advisory Boards for a variety of biotechnology and pharmaceutical companies.

Our clinical trial consultants also have extensive experience with the FDA, EMA (formerly EMEA) and other regulatory bodies. The FDA has repeatedly invited our consultants to present to CDER reviewers regarding PRO data and their role in the drug and medical device development process.

PRO Consulting has the most complete and diverse team of scientists experienced in PRO strategy and measurement, and with our corporate roots as a division of invivodata, we have the most relevant knowledge of PRO data collection methods.

Expert Consultants

Jean Paty, Ph.D. – Chief Scientist and Regulatory Advisor
Saul Shiffman, Ph.D. – Senior Scientific Consultant
Arthur Stone, Ph.D. – Senior Scientific Consultant

Senior Scientists
Peter M. Black, M.S.– Senior Scientific Consultant
Chad Gwaltney, Ph.D. – Senior Scientific Consultant
Katarina Halling – Senior Scientific Consultant
Brian Tiplady, Ph.D. – Senior Scientific Consultant
Scientists & Scientific Consultants
Celeste Elash, M.S. – Scientific Consultant
Oren Meyers, Ph.D.– Scientific Consultant
Chris Miller, Ph.D.– Scientific Consultant
Ashley Slagle, Ph.D. – Scientific Consultant
Meaghan St. Charles, Ph.D. – Scientific Consultant
Management Team
Bob Young– President, PRO Consulting